Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Blockade of SIV and HIV infection with CADA, a novel entry inhibitor that specifically targets the cellular CD4 receptor — Kurt Vermeire (2005) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Blockade of SIV and HIV infection with CADA, a novel entry inhibitor that specifically targets the cellular CD4 receptor
Shared by
De Clercq Erik
KU Leuven
Blockade of SIV and HIV infection with CADA, a novel entry inhibitor that specifically targets the cellular CD4 receptor
Article
2005
en
Authors
+2 more
KV
Kurt Vermeire
TB
Thomas W. Bell
RG
Roger Le Grand
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2006
The candidate microbicide CADA, an entry inhibitor that specifically targets the cellular CD4 receptor, prevents HIV and SIV infection of human and simian cells
Kurt Vermeire
,
Thomas W. Bell
,
S. Anugu
,
N.H. Duffy
,
Roger Le Grand
,
De Clercq Erik
,
Dominique Schols
Article
2006
Cyclotriazadisulfonamide (CADA) compounds, HIV entry inhibitors that specifically target the cellular CD4 receptor
Dominique Schols
,
Kristel Van Laethem
,
De Clercq Erik
,
Thomas W. Bell
,
Kurt Vermeire
Article
2005
Resistance profile of human immunodeficiency virus to CADA, a novel HIV inhibitor that targets the cellular CD4 receptor
Kurt Vermeire
,
Kristel Van Laethem
,
Anne‐Mieke Vandamme
,
Thomas W. Bell
,
De Clercq Erik
,
Dominique Schols
Article
2004
A novel class of HIV inhibitors that target the cellular CD4 receptor
Kurt Vermeire
,
T.W. Bell
,
De Clercq Erik
,
Dominique Schols
Article
2004
CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro
Kurt Vermeire
,
Katrien Princen
,
Sigrid Hatse
,
De Clercq Erik
,
K Dey
,
Thomas W. Bell
,
Dominique Schols
Discussion(0)
No comments yet. Be the first to comment.